You are here

Biomarkers and Diagnostics

Diagnostic, prognostic and predictive biomarkers and diagnostic tools and methods are available for licensing and/or collaborative development.

Highly accurate and robust multiplexed sequencing assay for the stratification of tissue/tumours into microsatellite instability high (MSI-H) vs microsatellite instability suppressed (MSS) subtypes

Read more

ORACLE is a new genetic test that combines machine learning with our understanding of tumour evolution to distinguish high- and low-risk lung tumours; it is also applicable to other tumours.

Read more

The Cox-2 Inflammatory Signature is a novel pan-cancer immuno-oncology predictive biomarker with strong proof of concept data on overall patient survival predictions across various malignancies.

Read more

CRUK is seeking a partner to collaborate on a proprietary technology better able to identify mutational patterns in cancer genomes for patient stratification.

Read more

Peptides with excellent affinity and selectivity for ɑvß6 have been identified and characterised.

Read more

Pages